The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The study will entail cognitive assessment of a single cohort of patients with Multiple Sclerosis. Each subject will be assessed twice, approximately 45 days apart. There will be no intervention or control group. Each participant will have a caregiver capable of responding to a brief report of observations regarding neuropsychological skills and abilities in the patient.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 65 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Individuals with Multiple Sclerosis
18 to 65 years old (inclusive).
History of Relapsing-Remitting or Secondary Progressive Multiple Sclerosis
Physically able to see the testing materials and complete the tests
Have a family member or caregiver who is capable of consent and willing to complete the MSNQ-Informant questionnaire.
A history of treated or untreated severe mental illness or diagnosis of major depression prior to MS onset.
Untreated major depression or untreated anxiety disorder.
History of Attention Deficit/Hyperactivity Disorder, Developmental Learning - Disorder including Mental Retardation.
History of traumatic brain injury with intracranial bleed, stroke, Alzheimer's disease, Parkinson's disease, Motor Coordination Disorder or other neurologic illness. I understand that if the Investigator believes this would interfere with successful completion of the protocol, I will be excluded.
A clinically significant relapse within the past 2 months. I have had a serious infection (e.g., pneumonia, septicemia) within the 2 month.
History of drug or alcohol abuse (as defined by the Investigator) within 1 year prior to Study Day 1.
Active bacterial or viral infection.
Use of marijuana within 2 months prior to Study Day 1or at any time during the study
Alcohol consumption within 24 hours of either test session.